JC polyomavirus granule cell neuronopathy in a patient treated with rituximab

JAMA Neurology

Volumn 71, Issue 4, 2014, Pages 487-489

  Dang, Louis ^a   Dang, Xin ^b   Koralnik, Igor J ^b   Todd, Peter K ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; ETIRACETAM; PREDNISONE; PROTEIN VP1; RITUXIMAB; VINCRISTINE SULFATE;

ARTICLE; ATAXIC DYSARTHRIA; AUTOPSY; CASE REPORT; CAUSE OF DEATH; CEREBELLUM ATROPHY; CEREBROSPINAL FLUID ANALYSIS; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE EXACERBATION; DNA SEQUENCE; DRUG EFFICACY; DYSARTHRIA; DYSDIADOCHOKINESIA; DYSMETRIA; EXTRAPYRAMIDAL SYMPTOM; FATIGUE; GENE FUNCTION; GENE IDENTIFICATION; HUMAN; HUMAN TISSUE; JC POLYOMAVIRUS GRANULE CELL NEURONOPATHY; JC VIRUS; LEUKOCYTE COUNT; LONG TERM CARE; LUMBAR PUNCTURE; LYMPHADENOPATHY; LYMPHOCYTE COUNT; MAINTENANCE THERAPY; MALE; MEDICAL HISTORY; MOLECULAR PATHOLOGY; MULTIPLE CYCLE TREATMENT; NEUROLOGIC EXAMINATION; NEUROPATHY; NONHODGKIN LYMPHOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOTIDE SEQUENCE; PATIENT ASSESSMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEIZURE; SEQUENCE ANALYSIS; VIRUS GENE; VIRUS IDENTIFICATION; VIRUS MUTATION; VIRUS STRAIN; VP1 GENE; WEIGHT REDUCTION;

AGED; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; CEREBELLAR ATAXIA; CYTOPLASMIC GRANULES; GAIT DISORDERS, NEUROLOGIC; HUMANS; JC VIRUS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MALE; TREATMENT OUTCOME;

EID: 84899015831     PISSN: 21686149     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaneurol.2013.4668     Document Type: Article

References (10)

1. Dang X, Vidal JE, Oliveira AC, et al. JC virus granule cell neuronopathy is associated with VP1 C terminus mutants. J Gen Virol. 2012;93(pt 1): 175-183.
2. Dang X, Koralnik IJ. A granule cell neuron-associated JC virus variant has a unique deletion in the VP1 gene. J Gen Virol. 2006;87(pt 9): 2533-2537.
3. Milbury CA, Li J, Makrigiorgos GM. Ice-COLD-PCR enables rapid amplification and robust enrichment for low-abundance unknown DNA mutations. Nucleic Acids Res. 2011;39(1):e2. doi:10.1093/nar/gkq899.
4. Gheuens S, Wüthrich C, Koralnik IJ. Progressive multifocal leukoencephalopathy: why gray and white matter. Annu Rev Pathol. 2013;8: 189-215.
5. Koralnik IJ, Wüthrich C, Dang X, et al. JC virus granule cell neuronopathy: A novel clinical syndrome distinct from progressive multifocal leukoencephalopathy. Ann Neurol. 2005;57(4): 576-580. (Pubitemid 40471172)
6. Du Pasquier RA, Corey S, Margolin DH, et al. Productive infection of cerebellar granule cell neurons by JC virus in an HIV+ individual. Neurology. 2003;61(6): 775-782. (Pubitemid 37174472)
7. Vermersch P, Kappos L, Gold R, et al. Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy. Neurology. 2011;76(20): 1697-1704.
8. Clifford DB, De Luca A, Simpson DM, Arendt G, Giovannoni G, Nath A. Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases. Lancet Neurol. 2010;9(4): 438-446.
9. published correction appears in Lancet Neurol. 2010;9(5):463
10. Schippling S, Kempf C, Büchele F, et al. JC virus granule cell neuronopathy and GCN-IRIS under natalizumab treatment. Ann Neurol. 2013;74(4): 622-626.